Association between antidiabetic drug use and the risk of COVID‐19 hospitalization in the INSIGHT Clinical Research Network in New York City

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 24; no. 7; pp. 1402 - 1405
Main Authors Min, JeaYoung, Simmons, Will, Banerjee, Samprit, Wang, Fei, Williams, Nicholas, Zhang, Yongkang, Reese, April B., Mushlin, Alvin I., Flory, James H.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2022
Wiley Subscription Services, Inc
Subjects
antidiabetic drug
Antidiabetics
Cohort analysis
cohort study
COVID-19
Diabetes
Diabetes mellitus
Epidemiology
Health risks
Hospitalization
Observational studies
observational study
pharmacoepidemiology
Research Letter
Research Letters
Severe acute respiratory syndrome coronavirus 2
type 2 diabetes
United States > US
New York City New York
antidiabetic drug
cohort study
type 2 diabetes
observational study
pharmacoepidemiology
Online AccessGet full text

Cover

More Information
Bibliography:Funding information
Patient Centered Outcomes Research Institute (PCORI), Grant/Award Number: CER‐2017C3‐9230; National Cancer Institute, Grant/Award Number: P30‐CA008748
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding information Patient Centered Outcomes Research Institute (PCORI), Grant/Award Number: CER‐2017C3‐9230; National Cancer Institute, Grant/Award Number: P30‐CA008748
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.14704